This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Abbott Diabetes Care granted preliminary injunction from UPC against SiBio

( February 20, 2025, 12:23 GMT | Official Statement) -- MLex Summary: Abbott Diabetes Care Inc. has won a preliminary injunction against SiBio Technology Limited at the Unified Patent Court, in a decision published today. The UPC Court of Appeal set aside the lower court's earlier order which had denied injunctive relief, and blocked sales of Sibionics’ GS1 continuous glucose monitoring device in multiple European countries where Abbott’s EP 3,831,283 is in force while the dispute remains active. The UPC ordered a penalty of 10,000 euros per infringing product from SiBio, or an alternative penalty of 100,000 euros per day of its non-compliance.See court document attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections